Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66

International Journal of Pharmaceutics

Volumn 260, Issue 2, 2003, Pages 273-282

  Carcaboso, A M ^a   Hernandez R M ^a   Igartua, M ^a   Gascon A R ^a   Rosas, J E ^b   Patarroyo, M E ^b   Pedraz, J L ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

Malaria; Microparticle; Oral administration; Poly D,L lactide co glycolide; SPf66; Vaccination

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; MALARIA SYNTHETIC PEPTIDE; MALARIA VACCINE; POLYGLACTIN; RESOMER; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENCAPSULATION; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; STOMACH INTUBATION; TH1 CELL;

EID: 0038121685     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00266-7     Document Type: Article

References (55)

1. Allaoui-Attarki K., Fattal E., Pecquet S., Trollé S., Chachaty E., Couvreur P., Andremont A. Mucosal immunogenicity elicited in mice by oral vaccination with phosphorilcholine encapsulated in poly(D,L-lactide-co-glycolide) microspheres. Vaccine. 16:1998;685-691.
2. Alonso P.L., Smith T., Schellenberg J.R., Masanja H., Mwankusye S., Urassa H. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet. 344:1994;1175-1181.
3. Barackman J.D., Singh M., Ugozzoli M., Ott G.S., O'Hagan D.T. Oral immunization with poly(lactide-co-glycolide) microparticles containing an entrapped recombinant glycoprotein (gD2) from herpes simplex type 2 virus. S.T.P. Pharm. Sci. 8:1998;41-46.
4. Bloom B.R. Vaccines for the third world. Nature. 342:1989;115-120.
5. Chandrashekhar U., Sinha S., Bhagat H.R., Srivastava B.S. Comparative efficacy of biodegradable liposomes and microspheres as carriers for delivery of Vibrio cholerae antigens in the intestine. Vaccine. 12:1994;1384-1388.
6. Chattaraj S.C., Rathinavelu A., Das S.K. Biodegradable microparticles of influenza viral vaccine: comparison of the effects of routes of administration on the in vivo immune response in mice. J. Control. Rel. 58:1999;223-232.
7. Conway M.A., Madrigal-Estebas L., McClean S., Brayden D.J., Mills K.H.G. Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells. Vaccine. 19:2001;1940-1950.
8. Coombes A.G.A., Lavelle E.C., Jenkins P.G., Davis S.S. Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen. Vaccine. 14:1996;1429-1438.
9. Desai M.P., Labhasetwar V., Amidon G.L., Levy R.J. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm. Res. 13:1996;1838-1845.
10. Doherty J.F., Pinder M., Tornieporth N., Carton C., Vigneron L., Milligan P. A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS, S/SBAS2 in semi-immune adults in the Gambia. Am. J. Trop. Med. Hyg. 61:1999;865-868.
11. Doherty T.M., Olsen A.W., Pinxteren L., Andersen P. Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis. Infect. Immun. 70:2002;3111-3121.
12. Eldridge J.H., Gilley R.M., Staas J.A., Moldoveanu Z., Meulbroek J.A., Tice T.R. Biodegradable microspheres: vaccine delivery system for oral immunization. Curr. Top. Microbiol. Immunol. 146:1989;59-66.
13. Felder Ch.B., Vorlaender N., Gander B., Merkle H.P., Bertschinger H.U. Microencapsulated enterotoxigenic Escherichia coli and detached fimbriae for peroral vaccination in pigs. Vaccine. 19:2001;706-715.
14. Flanagan M., Jain S., Michael J.G. Breaking of oral tolerance by encapsulated antigen. Ann. N.Y. Acad. Sci. 778:1994;373-375.
15. Friedman A., Weiner H.L. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. U.S.A. 91:1994;6688-6692.
16. Galindo C.M., Acosta C.J., Schellenberg D., Aponte J.J., Roca A., Oettli A. Humoral immune responses during a malaria vaccine trial in Tanzanian infants. Parasite Immunol. 22:2000;437-443.
17. Good, M.F., Saul, A., Graves, P.M., 1992. Malaria vaccines. In: Ellis, R.W. (Ed.), Vaccines. New Approaches to Immunological Problems. Butterworth-Heinemann, Stoneham, MA, pp. 69-98.
18. Gupta R.K. Aluminum compounds as vaccine adjuvants. Adv. Drug Del. Rev. 32:1998;155-172.
19. Gutierro I., Hernández R.M., Igartua M., Gascón A.R., Pedraz J.L. Size-dependant immune responses after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. Vaccine. 21:2002;67-77.
20. Igartua M., Hernández R.M., Esquisabel A., Gascón A.R., Calvo M.B., Pedraz J.L. Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres. J. Control. Rel. 56:1998;63-73.
21. Jung T., Kamm W., Breitenbach A., Hungerer K.-D., Hundt E., Kissel T. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinylalcohol)-graft-poly-(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice. Pharm. Res. 18:2001;352-360.
22. Katz D.E., DeLorimier A.J., Wolf M.K., Hall E.R., Cassels F.J., van J.E., Newcomer R.L., Davachi M.A., Taylor D.N., McQueen C.E. Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen. Vaccine. 21:2003;341-346.
23. Kende M., Yan C., Hewetson J., Frick M.A., Rill W.L., Tammariello R. Oral immunization of mice with ricin toxoid vaccine encapsulated in polymeric microspheres against aerosol challenge. Vaccine. 20:2002;1681-1691.
24. Lambert J.S., Keefer M., Mulligan M.J., Schwartz D., Mestecku J., Weinhold K., Smith C., Hsieh R., Moldoveanu Z., Fast P., Forrest B., Koff W. A Phase I safety and immunogenicity trial of UBI® microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects. Vaccine. 19:2001;3033-3042.
25. Maloy K.J., Donachie A.M., O'Hagan D.T., Mowat A.McI. Induction of mucosal and systemic responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Immunology. 81:1994;661-667.
26. Marx P.A., Compans R.W., Gettie A., Staas J.K., Gilley R.M., Mulligan M.J. Protection against vaginal SIV transmission with microencapsulated vaccine. Science. 260:1993;1323-1326.
27. Matsunaga Y., Wakatsuki Y., Tabata Y., Kawasaki H., Usui T., Yoshida M.et al. Oral immunization with size-purified microsphere beads as a vehicle selectively induces systemic tolerance and sensitization. Vaccine. 19:2001;579-588.
28. Men Y., Tamber H., Audran R., Gander B., Corradin G. Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres. Vaccine. 15:1997;1405-1412.
29. Merrifield R.B. Solid-phase peptide synthesis. Part I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:1963;2149-2154.
30. + Th1 cells. Vaccine. 13:1995;1741-1749.
31. Nardin E.H., Nussenzweig R.S. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu. Rev. Immunol. 11:1993;687-727.
32. Newman K.D., Sosnowski D.L., Kwon G.S., Samuel J. Delivery of MUC1 mucin peptide by poly(D,L-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses. J. Pharm. Sci. 87:1998;1421-1427.
33. Nixon D.F., Hioe C., Chen P., Bian Z., Klueber P., Li M.-L., Qiu H., Li X.-M., Singh M., Richardson J., McGee P., Zamb T., Koff W., Wang C.Y., O'Hagan D. Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity. Vaccine. 14:1996;1523-1530.
34. Noya O., Gabaldón Y., Alarcón B., Borges R., Zerpa N., Urbáez J.D. A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela. J. Infect. Dis. 170:1994;396-402.
35. O'Hagan, D.T., 1994. Microparticles as oral vaccines. In: O'Hagan, D.T. (Ed.), Novel Delivery Systems for Oral Vaccines. CRC Press, Boca Raton, FL, pp. 175-205.
36. Partidos C.D., Vohra P., Jones D.H., Farrar G., Steward M.W. Induction of cytotoxic T-cell responses following oral immunization with synthetic peptides encapsulated in PLG microparticles. J. Control. Rel. 62:1999;325-332.
37. Patarroyo M.E., Romero P., Torres M.L., Clavijo P., Moreno A., Martínez A. Induction of protective immunity against experimental infection with malaria using synthetic peptides. Nature. 328:1987;629-632.
38. Pecqet S., Leo E., Fritsché R., Pfeifer A., Couvreur P., Fattal E. Oral tolerance elicited in mice by β-lactoglobulin entrapped in biodegradable microspheres. Vaccine. 18:2000;1196-1202.
39. Pertmer T.M., Roberts T.R., Haynes J.R. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70:1996;6119-6125.
40. Richie T.L., Saul A. Progress and challenges for malaria vaccines. Nature. 415:2002;694-700.
41. Rosas J.E., Hernández R.M., Gascón A.R., Igartua M., Guzmán F., Patarroyo M.E., Pedraz J.L. Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66a. Vaccine. 19:2001;4445-4451.
42. Rosas J.E., Pedraz J.L., Hernández R.M., Gascón A.R., Igartua M., Guzmán F., Rodríguez R., Cortés J., Patarroyo M.E. Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after one single immunization of SPf66 encapsulated in PLGA microspheres. Vaccine. 20:2002;1707-1710.
43. Salcedo M., Barreto L., Rojas M., Moya R., Cote J., Patarroyo M.E. Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria. Clin. Exp. Immunol. 84:1991;122-128.
44. Scheicher C., Mehlig M., Dienes H.-P., Reske K. Uptake of microparticle-adsorbed protein antigen by bone marrow-derived dendritic cells results in up-regulation of interleukin-1a and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation. Eur. J. Immunol. 25:1995;1566-1572.
45. Seo J.-Y., Seong S.Y., Ahn B.-Y., Kwon I.C., Chung H., Jeong S.Y. Cross-protective immunity of mice induced by oral immunization with pneumococcal surface adhesin A encapsulated in microspheres. Infect. Immun. 70:2002;1143-1149.
46. Singh M., Briones M., Ott G., O'Hagan D.T. Cationic microparticles: a potent delivery system for DNA vaccines. Proc. Natl. Acad. Sci. U.S.A. 97:2000;811-816.
47. Smith D.J., Trantolo D.J., King W.F., Gusek E.J., Fackler P.H., Gresser J.D., De Souza V.L., Wise D.L. Induction of secretory immunity with bioadhesive poly(D,L-lactide-co-glycolide) microparticles containing Streptococcus sobrinus glucosyltransferase. Oral Microbiol. Immunol. 15:2000;124-130.
48. Stowers A.W., Cioce V., Shimp R.L., Lawson M., Hui G., Muratova O. Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial. Infect. Immun. 69:2001;1536-1546.
49. Tabata Y., Inoue Y., Ikada Y. Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. Vaccine. 14:1996;1677-1685.
50. Tsuji M., Zavala F. Peptide-based subunit vaccines against pre-erythrocytic stages of malaria parasites. Mol. Immunol. 38:2001;433-442.
51. Vordermeier H.M., Coombes A.G.A., Jenkins P., McGee J.P., O'Hagan D.T., Davis S.S., Singh M. Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles. Vaccine. 13:1995;1576-1582.
52. W.H.O., 2003. http://www.who.int/health-topics/malaria.htm
53. Wang R., Doolan D.L., Le T.P., Hedstrom R.C., Coonan K.M., Charoenvit Y. Induction of antigen-specific cytotoxic T lymphocytes in human by a malaria DNA vaccine. Science. 282:1998;476-480.
54. van de Weert M., Hennink W.E., Jiskoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm. Res. 17:2000;1159-1167.
55. Yeh M.-K., Liu Y.T., Chen J.-L., Chiang C.-H. Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles. J. Control. Rel. 82:2002;237-247.